End-to-end pharmaceutical development and supply chain, including clinical trials, raw materials, APIs, contract manufacturers, brands, distribution, retail, regulations, marketing, etc.

The Coming Wave of Pharma Supply Chain Regulations: Insights from TraceLink NEXUS ’15

New regulations across the globe are coming into effect, requiring pharmaceutical manufacturers, distributors, dispensers, and others up and down the chain to build serialization, verification, and traceability into the supply chain. At TraceLink’s NEXUS ’15 conference, we learned a lot about the impact of these new requirements, how companies are responding, and whether there is an ROI beyond compliance.

Supply Chain Risk Now?

The supply chain business community now includes Risk Management as a business priority and cites it as a key area in need of improvement. Are solution providers ready?

Trends in Healthcare / Life Sciences and Their Impact on Electronic Commerce

ACA and HIPAA standards mean big changes in electronic commerce in healthcare.

With healthcare costs soaring, administrative costs comprising a whopping 7% of healthcare expenses, and increased concerns about medical errors and counterfeiting, to name a few challenges, various government agencies in the US are taking legislative action.

This report addresses the most recent changes impacting those who trade in the US market–across the whole value chain–and the impact the Affordable Care Act and other recent legislation will have on the deployment of standard electronic commerce communications.

RFID in Pharmaceuticals

The discussion has moved from if to how for many major pharmaceutical manufacturers. The barriers to adoption are down and the benefits are up. So you may have a good reason to look at solutions now.

Scroll to Top